Published in Eur J Cancer Clin Oncol on November 01, 1989
Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J (1995) 2.23
Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. Arch Dermatol (2001) 2.16
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia (2006) 2.03
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J (2010) 1.83
The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood (1997) 1.75
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63
Knowledge and attitudes of Italian medical staff towards the approach and treatment of patients in pain. J Pain Symptom Manage (2001) 1.60
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol (1998) 1.56
Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation. Leukemia (1994) 1.54
Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Dig Dis Sci (1989) 1.47
Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol (2001) 1.46
Overcoming national and cultural differences within collaborative international nursing research. West J Nurs Res (1996) 1.39
Multiple radiculopathy of the lower limbs in a cancer patient with meningeal carcinomatosis. Neurol Sci (2000) 1.38
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma. J Hematother Stem Cell Res (2000) 1.37
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations. Ann N Y Acad Sci (1986) 1.30
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS (1994) 1.29
CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med (2000) 1.27
State of the art in natural killer cell malignancies. Int J Lab Hematol (2011) 1.26
Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol (1998) 1.24
CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol (1999) 1.23
Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells. Am J Pathol (1988) 1.23
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol (1996) 1.21
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med (1994) 1.19
Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis (1985) 1.18
Hair casts are a dermoscopic clue for the diagnosis of traction alopecia. Br J Dermatol (2010) 1.17
New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol (2000) 1.16
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer (1987) 1.15
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood (1997) 1.14
Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol (1995) 1.11
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (1988) 1.10
The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest (1999) 1.09
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer (1987) 1.09
CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood (1995) 1.05
Diffuse hypertrichosis during treatment with 5% topical minoxidil. Br J Dermatol (1997) 1.05
Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin Exp Immunol (1984) 1.03
Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med (1996) 1.03
HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis (1993) 1.02
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant (2008) 1.01
Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol (1995) 1.01
Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes. Blood (1993) 1.00
Allergic contact dermatitis due to povidone-iodine. Contact Dermatitis (1990) 0.99
Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition. Cancer Res (1991) 0.99
Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am Rev Respir Dis (1988) 0.99
T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study. Cancer (1981) 0.99
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia (2013) 0.99
Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Hum Pathol (1992) 0.97
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood (1996) 0.97
Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends Immunol (2001) 0.97
Oxaliplatin: available data in non-colorectal gastrointestinal malignancies. Crit Rev Oncol Hematol (2001) 0.97
Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies. J Clin Immunol (1987) 0.97
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood (1987) 0.97
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. Cancer (1985) 0.96
Radiotherapy for non-small cell lung cancer in patients aged 75 and over: safety, effectiveness and possible impact on survival. Lung Cancer (2000) 0.96
Rituximab-responsive CIDP. Eur J Neurol (2004) 0.96
Screening of high shear mixer melt granulation process variables using an asymmetrical factorial design. Int J Pharm (1999) 0.95
The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2001) 0.95
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am J Physiol (1999) 0.95
Changes of biological features in breast cancer cells determined by primary chemotherapy. Breast Cancer Res Treat (1997) 0.94